Docket of HB513
Bill Title: relative to affordability and safety of clinician administered drugs.
| Date | Body | Description |
|---|---|---|
| 01/11/2023 | House | Introduced (opens in new window) (in recess of) 01/05/2023 and referred to Commerce and Consumer Affairs HJ 3 P. 19 |
| 02/03/2023 | House | ==CANCELLED== Public Hearing: 02/07/2023 02:15 pm LOB 210-211 |
| 02/09/2023 | House | Public Hearing: 02/15/2023 02:00 pm LOB 302-304 |
| 02/23/2023 | House | Subcommittee Work Session: 03/08/2023 10:00 am LOB 302-304 |
| 02/23/2023 | House | Executive Session: 03/08/2023 01:15 pm LOB 302-304 |
| 03/08/2023 | House | Executive Session: 03/15/2023 11:00 am LOB 302-304 |
| 03/08/2023 | House | Subcommittee Work Session: 03/15/2023 10:05 am LOB 302-304 |
| 03/15/2023 | House | Retained in Committee |
| 08/30/2023 | House | ==CANCELLED== Subcommittee Work Session: 09/06/2023 01:15 pm LOB 302-304 |
| 09/06/2023 | House | ==RESCHEDULED== Subcommittee Work Session: 09/20/2023 01:15 pm LOB 302-304 HC 36 |
| 10/17/2023 | House | ==RECESSED== Executive Session: 11/08/2023 01:30 pm LOB 302-304 HC 42 |
| 11/08/2023 | House | ==CANCELLED== Executive Session: 11/15/2023 11:00 am LOB 302-304 HC 42 |
| 11/16/2023 | House | Committee Report: Refer for Interim Study 11/08/2023 (Vote 19-0; CC) HC 49 P. 5 |
| 01/03/2024 | House | Refer for Interim Study: MA VV 01/03/2024 HJ 1 P. 36 |
| 08/14/2024 | House | Full Committee Work Session: 09/12/2024 10:00 am LOB 302-304 |
| 09/25/2024 | House | Executive Session: 10/17/2024 10:00 am LOB 302-304 |
| 10/31/2024 | House | Interim Study Report: Not Recommended for Future Legislation (Vote 16-0) |